Redhill Biopharma Ltd (RDHL) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $0.98
• Market Cap: $4.91M
• 52-Week High: $3.60
• 52-Week Low: $0.91

Market Sentiment

Redhill Biopharma Ltd currently has a Bullish sentiment score of 0.24.

About Redhill Biopharma Ltd

RedHill Biopharma Ltd. (RDHL) is a Tel Aviv-based specialty biopharmaceutical company focused on developing and commercializing innovative therapeutic solutions primarily for gastrointestinal and infectious diseases. The company boasts a promising pipeline that features proprietary products alongside strategic partnerships, aimed at addressing substantial unmet medical needs. Leveraging its advanced clinical research capabilities and regulatory expertise, RedHill is strategically positioned t...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Redhill Biopharma Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does RDHL pay dividends?

Redhill Biopharma Ltd (RDHL) does not currently pay a regular dividend.

What is RDHL's market cap?

Redhill Biopharma Ltd (RDHL) has a market capitalization of $4.91M with a current stock price of $0.98.